Acadia Healthcare (NASDAQ:ACHC) Trading Down 9.1% – Time to Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price dropped 9.1% during trading on Friday . The company traded as low as $53.31 and last traded at $53.90. Approximately 1,817,163 shares were traded during trading, an increase of 101% from the average daily volume of 903,816 shares. The stock had previously closed at $59.32.

Analysts Set New Price Targets

ACHC has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Royal Bank of Canada restated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research report on Friday, September 20th. KeyCorp started coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Barclays cut their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $86.67.

Acadia Healthcare Stock Performance

The stock has a market capitalization of $4.83 billion, a price-to-earnings ratio of -371.64, a PEG ratio of 1.57 and a beta of 1.29. The stock’s 50 day moving average is $70.74 and its 200 day moving average is $69.51. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. During the same period in the prior year, the company earned $0.92 EPS. The firm’s revenue was up 8.8% on a year-over-year basis. On average, analysts predict that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently modified their holdings of the company. GAMMA Investing LLC boosted its stake in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the last quarter. Commonwealth Equity Services LLC boosted its stake in shares of Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the last quarter. Quent Capital LLC boosted its stake in shares of Acadia Healthcare by 8.1% during the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock worth $300,000 after purchasing an additional 284 shares during the last quarter. Finally, Retirement Systems of Alabama boosted its position in shares of Acadia Healthcare by 0.3% in the first quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock worth $9,174,000 after acquiring an additional 303 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.